We are live on
!
Find out more
BIA
Biondo Investment Advisors Portfolio holdings
AUM
$780M
1-Year Est. Return
21.03%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$231M
AUM Growth
–
Cap. Flow
+$227M
Cap. Flow
% of AUM
98.38%
Top 10 Holdings %
Top 10 Hldgs %
54.5%
Holding
87
New
87
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$16.7M |
| 2 |
Ford
F
|
+$15.9M |
| 3 |
JPM.WS
JPMorgan Chase
JPM.WS
|
+$15.9M |
| 4 |
Intuitive Surgical
ISRG
|
+$15.7M |
| 5 |
CELG
Celgene Corp
CELG
|
+$14.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.83% |
| 2 | Financials | 17.22% |
| 3 | Industrials | 10.78% |
| 4 | Consumer Discretionary | 9.58% |
| 5 | Technology | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Mastercard
MA
$469B
| $17.3M | 7.49% |
+300,570
| New | +$16.7M |
|
|
2
Ford
F
$56.4B
| $17.1M | 7.43% |
+1,107,384
| New | +$15.9M |
|
|
JPM.WS
3
DELISTED
JPMorgan Chase
JPM.WS
| $16.9M | 7.33% |
+1,082,947
| New | +$15.9M |
|
|
4
Intuitive Surgical
ISRG
$119B
| $16M | 6.95% |
+285,120
| New | +$15.7M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $14.5M | 6.28% |
+247,770
| New | +$14.9M |
|
6
Bank of America
BAC
$430B
| $11.8M | 5.12% |
+917,399
| New | +$11.7M |
|
|
GTLS
7
DELISTED
Chart Industries
GTLS
| $10.4M | 4.5% |
+110,325
| New | +$9.65M |
|
8
Apple
AAPL
$4.72T
| $7.67M | 3.33% |
+541,716
| New | +$8.33M |
|
9
Idexx Laboratories
IDXX
$42.5B
| $7.38M | 3.2% |
+164,490
| New | +$7.19M |
|
10
JPMorgan Chase
JPM
$930B
| $6.64M | 2.88% |
+125,875
| New | +$6.4M |
|
11
Illumina
ILMN
$29.8B
| $5.2M | 2.26% |
+71,436
| New | +$4.57M |
|
12
Pacira BioSciences
PCRX
$1.02B
| $5.15M | 2.23% |
+177,490
| New | +$5.13M |
|
13
Gilead Sciences
GILD
$162B
| $5.1M | 2.21% |
+99,395
| New | +$5.18M |
|
14
Boeing
BA
$165B
| $4.79M | 2.08% |
+46,760
| New | +$4.44M |
|
15
Alphabet (Google) Class C
GOOG
$3.89T
| $4.53M | 1.97% |
+206,772
| New | +$4.37M |
|
|
MON
16
DELISTED
Monsanto Co
MON
| $4.48M | 1.94% |
+45,352
| New | +$4.75M |
|
17
Qualcomm
QCOM
$180B
| $3.46M | 1.5% |
+56,639
| New | +$3.61M |
|
|
BEAV
18
DELISTED
B/E Aerospace Inc
BEAV
| $3.39M | 1.47% |
+74,314
| New | +$3.35M |
|
|
CRR
19
DELISTED
Carbo Ceramics Inc.
CRR
| $2.21M | 0.96% |
+32,770
| New | +$2.43M |
|
|
MAKO
20
DELISTED
MAKO SURGICAL CORP COM
MAKO
| $2.18M | 0.94% |
+180,700
| New | +$2.05M |
|
21
Amgen
AMGN
$201B
| $1.97M | 0.85% |
+19,965
| New | +$2.07M |
|
22
ConocoPhillips
COP
$146B
| $1.9M | 0.83% |
+31,456
| New | +$1.91M |
|
23
FMC
FMC
$1.46B
| $1.9M | 0.82% |
+35,857
| New | +$1.89M |
|
24
Bristol-Myers Squibb
BMY
$126B
| $1.88M | 0.81% |
+41,956
| New | +$1.82M |
|
25
Core Laboratories
CLB
$544M
| $1.85M | 0.8% |
+12,210
| New | +$1.73M |
|
Similar funds
LA
UBV
SG
RTM
TCMX
QCMNJ
TIS
MO
Biondo Investment Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Biondo Investment Advisors, which disclosed 87 positions worth $231M. Its ten largest holdings account for 55% of the portfolio.
Its largest position is Mastercard: 300,570 shares worth $17.3M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, followed by Financials and Industrials.
- Biondo Investment Advisors's largest Q2 2013 buy was Mastercard: 300,570 shares worth $17.3M.
- Biondo Investment Advisors's ten largest holdings make up 55% of its $231M portfolio in Q2 2013.
- Biondo Investment Advisors disclosed 87 positions in Q2 2013, its first 13F filing on record.
Based on Biondo Investment Advisors's 13F filing for Q2 2013, filed 17 Jul 2013.